“…So far, multi‐class Nbs targeting different mycotoxins—for example, OTA (Xie et al., 2022), AFB 1 (Liu et al., 2020; Zuo, Yan et al., 2023), tenuazonic acid (Wang, Yang et al., 2022), FB 1 (Alsulami et al., 2021)—have been explored. In addition, the controllable recombination of Nbs with other biomolecules and the construction of multimeric Nbs multimerization are facilitate to prepare novel immunosensing systems for mycotoxin monitoring, including dual‐mode immunosensors (Zuo, Yan et al., 2023), chemiluminescent ELISA (Wang et al., 2023), bioluminescent ELISA (Bao et al., 2022), Nanobody/NanoBiT system‐based (Xie et al., 2022), and FRET‐based immunosensors (Su et al., 2022). Besides being utilized as the primary Abs to recognize targets, Nbs can also be applied as signal indicator‐labeled secondary Abs, which results in a significant enhancement of analytical sensitivity, which is the so‐called anti‐idiotypic Nbs by using mAbs as the immunogens (Cai et al., 2021; Tang et al., 2022).…”